Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Upadacitinib for moderate to severe atopic dermatitis.
Navarro-Triviño F, Alcantara-Luna S, Domínguez-Cruz J, Galán-Gutiérrez M, Ruiz-Villaverde R, Pereyra-Rodriguez JJ, Armario-Hita JC. Navarro-Triviño F, et al. Among authors: alcantara luna s. Immunotherapy. 2023 Aug;15(11):799-808. doi: 10.2217/imt-2023-0037. Epub 2023 May 17. Immunotherapy. 2023. PMID: 37194577 Review.
Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis.
Pereyra-Rodriguez JJ, Alcantara-Luna S, Domínguez-Cruz J, Galán-Gutiérrez M, Ruiz-Villaverde R, Vilar-Palomo S, Armario-Hita JC. Pereyra-Rodriguez JJ, et al. Among authors: alcantara luna s. Life (Basel). 2021 Sep 6;11(9):927. doi: 10.3390/life11090927. Life (Basel). 2021. PMID: 34575076 Free PMC article. Review.
Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review.
Ayen-Rodríguez A, Pereyra-Rodríguez JJ, Navarro-Triviño FJ, Alcantara-Luna S, Domínguez-Cruz J, Galán-Gutiérrez M, Vilar-Palomo S, Armario-Hita JC, Ruiz-Villaverde R. Ayen-Rodríguez A, et al. Among authors: alcantara luna s. Life (Basel). 2022 Jul 30;12(8):1159. doi: 10.3390/life12081159. Life (Basel). 2022. PMID: 36013338 Free PMC article. Review.
Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results.
Pereyra-Rodriguez JJ, Herranz P, Figueras-Nart I, Perez B, Elosua M, Munera-Campos C, Melgosa-Ramos J, Zaragoza V, Silvestre JF, Campos-Domínguez M, Guilabert A, Miquel J, Alcantara-Luna S, Serra-Baldrich E, Armario-Hita JC. Pereyra-Rodriguez JJ, et al. Among authors: alcantara luna s. J Investig Allergol Clin Immunol. 2023 Jun 15;33(3):211-213. doi: 10.18176/jiaci.0831. Epub 2022 Jun 7. J Investig Allergol Clin Immunol. 2023. PMID: 35671128 Free article. No abstract available.
Entwicklung und Validierung eines Fragebogens zur Messung des Empowerments bei erwachsenen Patienten mit atopischer Dermatitis. Der DATEMP-Fragebogen.
Pereyra-Rodriguez JJ, Dominguez-Cruz JJ, Hernandez-Montoya C, Galan-Gutiérrez M, Martín Carrasco P, Alcántara Luna S, Navarro-Triviño FJ, Del Pozo J, Ruiz-Villaverde R. Pereyra-Rodriguez JJ, et al. Among authors: alcantara luna s. J Dtsch Dermatol Ges. 2019 Sep;17(9):923-932. doi: 10.1111/ddg.13934_g. J Dtsch Dermatol Ges. 2019. PMID: 31538726 German.
Upadacitinib for the Treatment of Atopic Dermatitis in a Spanish Cohort-Real Life: Fifty-Two-Week Follow-up Results.
Pereyra-Rodriguez JJ, Herranz P, Figuras-Nart I, Perez B, Elosua M, Munera-Campos M, Melgosa-Ramos J, Zaragoza Ninet V, Silvestre JF, Campos-Domínguez M, Guilabert A, Miquel J, Alcantara-Luna S, de la Cueva P, Serra-Baldrich E, Armario-Hita JC. Pereyra-Rodriguez JJ, et al. Among authors: alcantara luna s. Dermatitis. 2022 Nov-Dec 01;33(6S):S124-S127. doi: 10.1097/DER.0000000000000958. Epub 2022 Sep 21. Dermatitis. 2022. PMID: 36125777 No abstract available.
12 results